Glycosylation changes are commonly observed in cancer cells, including increased sialyl Lewis structures, irregular core fucosylation, an increase in N-glycan branching, or exposure of the mucin-type O-glycan, which may result in the production of unique tumor antigens that could be promising targets for immune therapy (Holmes et al., 1987). Here, MUC5AC is linked to cancer.